Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP‐164 study)

Patients with transplant‐ineligible relapsed and refractory multiple myeloma (RRMM) have a short life expectancy, especially when they have failed both the proteasome inhibitor and immunomodulator therapies. This study aimed to assess the efficacy and safety of pomalidomide, cyclophosphamide, and de...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Hematol
Main Authors: Lee, Ho Sup, Kim, Kihyun, Kim, Seok Jin, Lee, Je‐Jung, Kim, Inho, Kim, Jin Seok, Eom, Hyeon‐Seok, Yoon, Dok Hyun, Suh, Cheolwon, Shin, Ho‐Jin, Mun, Yeung‐Chul, Kim, Min Kyoung, Lim, Sung‐Nam, Choi, Chul Won, Kang, Hye Jin, Yoon, Sung‐Soo, Min, Chang‐Ki
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2020
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983889/
https://ncbi.nlm.nih.gov/pubmed/31919872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25726
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares